Issue 10, 2015

Synthesis and DFT studies of an antitumor active spiro-oxindole

Abstract

An anti-oncological active spiro-oxindole 7 was synthesized regioselectively via a [3+2]-cycloaddition reaction of azomethine ylide to exocyclic olefinic linkage of 4-piperidone 6, exhibiting properties against diverse tumor cell lines including leukemia, melanoma and cancers of the lung, colon, brain, ovary, breast, prostate, and kidney. Compound 7 crystallizes in the monoclinic system and P21/c space group with four molecules in the unit cell. The structure was also studied by AM1, PM3 and DFT techniques. DFT studies support the stereochemical selectivity of the reaction and determine the molecular electrostatic potential and frontier molecular orbitals.

Graphical abstract: Synthesis and DFT studies of an antitumor active spiro-oxindole

Supplementary files

Article information

Article type
Paper
Submitted
03 May 2015
Accepted
30 Jul 2015
First published
05 Aug 2015

New J. Chem., 2015,39, 8017-8027

Author version available

Synthesis and DFT studies of an antitumor active spiro-oxindole

A. S. Girgis, A. F. Mabied, J. Stawinski, L. Hegazy, R. F. George, H. Farag, E. M. Shalaby and I. S. A. Farag, New J. Chem., 2015, 39, 8017 DOI: 10.1039/C5NJ01109D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements